SI Stock Forecast & Price Target

Shoulder Innovations Inc. demonstrated significant growth in its second quarter of 2025, reporting total revenue of $11.8 million, which represents a 58% increase and surpassed expectations by $1.8 million. The company successfully increased its surgeon adoption rates, highlighted by the addition of new Core Contender surgeons, projected to grow at an approximate rate of 11 per quarter moving forward. With an enhanced balance sheet and a favorable market outlook, Shoulder Innovations is well-positioned to expand its commercial initiatives and sustain strong top-line growth in the future.

Shoulder Innovations, Inc. has reported a significant adjusted EBITDA loss of $7.5 million, which exceeded prior models by approximately $400,000, indicating potential financial distress. The company's outlook is further strained by challenges such as slower product adoption by new surgeons, lower overall market growth rates for shoulder surgeries, and higher-than-anticipated operational expenses. Additionally, factors including accelerated average selling price (ASP) degradation and delayed market entry into new segments contribute to an unfavorable financial trajectory, as evidenced by a total EBITDA loss of $35.9 million.